Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies

Suelen Lucio Boschen, James Trevathan, Seth A. Hara, Anders Asp, J. Luis Lujan

Research output: Contribution to journalReview articlepeer-review


Fast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in bringing FSCV into clinical use. However, there remain technical challenges that limit clinical implementation of FSCV by creating barriers to appropriate scientific rigor and patient safety. In order to progress with clinical FSCV, these limitations must be first addressed through (1) appropriate pre-clinical studies to ensure accurate measurement of neurotransmitters and (2) the application of a risk management framework to assess patient safety. The intent of this work is to bring awareness of the current issues associated with FSCV to the scientific, engineering, and clinical communities and encourage them to seek solutions or alternatives that ensure data accuracy, rigor and reproducibility, and patient safety.

Original languageEnglish (US)
Article number728092
JournalFrontiers in Neuroscience
StatePublished - Nov 12 2021


  • clinical neurochemistry
  • deep brain stimulation
  • fast scan cyclic voltammetry
  • intraoperative
  • neurochemical signaling
  • neurophysiology

ASJC Scopus subject areas

  • General Neuroscience


Dive into the research topics of 'Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies'. Together they form a unique fingerprint.

Cite this